| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |